Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients.

Michele Magnocavallo,Luigi Di Biase,Luca Di Lullo,Andrea Natale,Amin Al-Ahmad,Mohamed Bassiouny,J David Burkhardt,Giampaolo Vetta,Carlo Lavalle,Cristina Chimenti,Domenico G Della Rocca,Sanghamitra Mohanty,Rodney P Horton,Carola Gianni,Javier E Sanchez,Donatello Cirone,Armando Del Prete,G Joseph Gallinghouse

doi:10.1016/j.ccep.2021.10.001

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients.

Michele Magnocavallo, Luigi Di Biase + Show 16 more

Open Access

https://doi.org/10.1016/j.ccep.2021.10.001

Copy DOI

Journal: Cardiac electrophysiology clinics	Publication Date: Jan 22, 2022
Citations: 8	License type: NO-CC CODE

Affiliation: Sapienza University of Rome, St David's Medical Center, Policlinico Umberto I, Texas Cardiac Arrhythmia, Children's Hospital at Montefiore, Albert Einstein College of Medicine, CTO Hospital, Case Western Reserve University, MetroHealth Medical Center, Scripps Clinic, Azienda Ospedaliero-Universitaria Careggi, Ospedale Santa Maria Goretti

#Pathogenesis Of Cardiac Arrhythmias #Acute Coronary Syndromes + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

Full Text